Fly Intel: Top five analyst downgrades

downgraded Cronos Group Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Amarin (AMRN) downgraded to Hold from Buy at Jefferies with analyst Michael Yee expecting the stock to be range-bound until there is more clarity on an appeal to last night's negative patent decision and scenarios where generics may not immediately hit. 2. Hexo (HEXO) downgraded to Hold from Buy at Desjardins with analyst John Chu saying near-term funding requirements overshadow better than expected Q2 adjusted EBITDA loss as the company will need up to C$55M in equity financing by April 30. 3. Baker Hughes (BKR) downgraded to Hold from Buy at Argus withanalyst Bill Selesky warning that dramatically lower crude oil prices and demand impact of COVID-19 will lead to greater oil supply imbalances and a sharp deceleration in drilling activity starting in Q2. 4. Venus Concept (VERO) downgraded to Perform from Outperform at Oppenheimer as COVID-19 clouds outlook with analyst Suraj Kalia noting that the COVID-19 situation has forced the company to pull fiscal year 2020 guidance, therefore leaving a level of uncertainty in numbers. 5. Cronos Group (CRON) downgraded to Sell from Hold at Canaccord with analyst sayinh Q4 results came in below expectations on a modest top-line improvement, inventory write-offs, and deepening adjusted EBITDA losses. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.